Crohn's Disease Biologics: How They Work, Side Effects, and Flares on Treatment

9 min · Written by a Crohn's patient on biologic therapy

You start a biologic, you wait a few weeks, and somewhere between your third infusion and your next scope, you notice you're actually feeling better. Then six months later, symptoms come back. Or side effects you weren't warned about are making daily life harder than the Crohn's itself.

This guide covers what biologic therapy for Crohn's disease actually looks like from a patient perspective: how the drugs work, what side effects are common versus rare, and what it really means to flare while on treatment.

This article is written for informational purposes and based on personal patient experience. It is not a substitute for medical advice. Always consult your gastroenterologist before making any changes to your treatment.

How biologics work for Crohn's disease

Biologics are proteins engineered to block specific molecules in your immune system that drive inflammation. They are not traditional drugs that suppress immunity across the board. They target one particular pathway.

Most biologics prescribed for Crohn's block a molecule called TNF-alpha (tumor necrosis factor-alpha). TNF-alpha is one of the main chemical signals that triggers inflammation in the gut wall. When it is blocked, the inflammatory cascade slows, the intestinal lining gets a chance to heal, and symptoms like pain and diarrhea improve.

Some biologics work differently:

• Vedolizumab (Entyvio) prevents immune cells from entering the gut specifically, without broadly affecting systemic immunity.
• Ustekinumab (Stelara) targets different inflammatory signals: IL-12 and IL-23.
• Risankizumab (Skyrizi) blocks IL-23 only, a more selective approach approved more recently for Crohn's.

The key point: biologics do not switch your immune system off. They redirect it away from attacking your gut. That distinction shapes how side effects and infection risks actually work in practice.

The Crohn's & Colitis Foundation has a detailed overview of how biologic therapies are used for IBD if you want a clinical reference alongside this patient-level read.

The main biologics used for Crohn's

Drug (generic)	Brand name	Target	How it's given	Typical schedule
Infliximab	Remicade	TNF-alpha	IV infusion	Weeks 0, 2, 6 then every 8 weeks
Adalimumab	Humira	TNF-alpha	Self-injection	Every 2 weeks
Vedolizumab	Entyvio	Gut-selective integrin	IV infusion	Weeks 0, 2, 6 then every 8 weeks
Ustekinumab	Stelara	IL-12 / IL-23	IV then self-injection	IV loading dose, then every 8 or 12 weeks
Risankizumab	Skyrizi	IL-23	IV then self-injection	IV loading dose, then every 8 weeks

Your gastroenterologist will choose based on your disease location and severity, previous treatments, other health conditions (psoriasis and arthritis change the picture), and insurance coverage. There is no universally "best" biologic for Crohn's, which partly explains why patient responses vary so much.

Crohn's disease biological treatment side effects: what is normal

Side effects from biologic therapy are real, but manageable for most patients. The difference between tolerating treatment well and struggling with it often comes down to knowing what to expect and what actually needs a call to your IBD team.

Reactions during or just after administration

For infusions (Remicade, Entyvio, Stelara loading dose), about 5 to 10% of patients notice a reaction during the drip: flushing, headache, chills, or a slight drop in blood pressure. These infusion reactions are usually handled on-site by slowing the drip rate or pre-medicating with an antihistamine and paracetamol. Severe reactions are uncommon.

For self-injections (Humira, Skyrizi, Stelara maintenance), local skin reactions are the most frequent complaint: redness, swelling, or stinging at the injection site. These typically fade within 24 to 48 hours and often improve as you get used to the injection technique and rotating sites.

Side effects during long-term biologic therapy

The main ongoing concern with Crohn's disease biological treatment is infection risk. Because these drugs reduce specific immune activity, your body may take slightly longer to clear certain infections. Here is what to watch for:

• Respiratory infections (colds, sinusitis, bronchitis) may last a few extra days. Treat them early rather than waiting.
• Skin infections need prompt antibiotic treatment. Do not wait to see if they clear on their own.
• Fever above 38.5°C without a clear cause: contact your IBD team the same day, not at your next scheduled appointment.
• Persistent cough, unexplained weight loss, or night sweats: report these immediately. They can be signs of tuberculosis reactivation. Your gastro will have screened for TB before starting, but ongoing vigilance matters.

Other side effects reported by patients on TNF blockers include fatigue (which is hard to separate from Crohn's fatigue itself), joint pain, and occasionally skin reactions resembling psoriasis. These are less frequent with gut-selective biologics like vedolizumab.

According to a safety review of IBD biologics published via PubMed, serious adverse events remain relatively low when patients are monitored regularly, with infections being the most common reason for treatment interruption.

Rare but serious risks to know about

Biologics carry a small increased risk of serious infections and, in rare cases, certain lymphomas. These risks are real and should not be dismissed. They should also be weighed against the risks of uncontrolled Crohn's disease over years: permanent bowel damage, strictures, fistulas, and surgery. Your gastroenterologist is factoring in both sides every time they recommend or continue a biologic.

Flaring while on biologic therapy: what is actually happening

Getting a flare on biologic treatment is one of the most confusing experiences in managing Crohn's. You're doing everything right. Symptoms come back anyway. Here is what is usually going on under the surface.

Loss of drug response versus functional symptoms

Your IBD team will try to distinguish between two different situations:

1. Loss of biologic efficacy. Over time, some patients develop antibodies against their biologic, particularly against TNF-alpha inhibitors like infliximab and adalimumab. These antibodies neutralize the drug before it can act. A blood test measuring drug trough levels and anti-drug antibodies is the starting point. If levels are low without antibodies, increasing the dose or shortening the interval often restores response. If antibodies are high, switching to a biologic with a different mechanism is usually the next step.

2. Functional symptoms without active inflammation. Sometimes stool frequency or cramping returns, but blood markers (CRP, fecal calprotectin) and scopes show no active inflammation. This is not treatment failure. It often reflects IBS-like symptoms that overlap with Crohn's, related to stress, diet, or gut motility, and requires completely different management. Treating this as biologic failure would be the wrong call.

This is why your doctor will not switch your treatment based on symptoms alone. Objective testing comes first.

What your IBD team will do next

A typical workup when you report a flare on biological treatment for Crohn's includes:

1. CRP (C-reactive protein) and full blood count to check for systemic inflammation
2. Fecal calprotectin, a stool marker that is highly sensitive to gut wall inflammation
3. Drug level and anti-drug antibody blood test specific to your biologic
4. Colonoscopy or imaging if markers point to active disease

Based on those results, options include dose escalation, adding an immunomodulator (azathioprine or methotrexate), or switching to a biologic from a different class. If you have been logging your symptoms consistently, that data will give your doctor useful context during this workup. See our guide to managing a Crohn's flare step by step for what to track during this period.

Practical tips for daily life on biologic therapy

A few things that make a real difference over the long term:

• Vaccines before you start. Live vaccines (yellow fever, varicella if you have never had chickenpox) must be given before beginning biologic therapy. Once on treatment, inactivated vaccines (flu, COVID, hepatitis B, shingles inactivated version) remain safe. Live vaccines do not. IBD Passport has a practical vaccination checklist worth printing before your first appointment.
• Every medical provider needs to know. Dentists, surgeons, GPs, and emergency doctors all need to know you are on a biologic. Some procedures require a temporary pause in treatment.
• Keep your patient card on you. Most biologics come with one. It lists the drug name, dose, and emergency contacts. Keep it in your wallet or saved on your phone.
• Report new skin changes without delay. A rash on the scalp, elbows, or palms can signal a drug-related side effect. A photo sent to your IBD nurse is enough. Do not wait for a scheduled appointment to mention it.
• Do not skip doses when you feel well. Feeling good is often proof the biologic is working. Gaps in treatment are among the most common triggers for antibody formation and loss of response.

Understanding which symptoms come from active Crohn's versus biologic side effects versus food choices is genuinely useful data. Tracking meals alongside daily symptoms, particularly in the months after starting or switching a biologic, makes patterns visible that are otherwise hard to see. Our guide on Crohn's disease trigger foods covers how dietary factors overlap with treatment response.

Biologics during pregnancy

One of the most frequent questions from patients of childbearing age: are biologics safe during pregnancy?

Current gastroenterology guidelines broadly agree that most biologics can be continued through at least the second trimester. Active, uncontrolled Crohn's during pregnancy carries higher risks for both mother and baby than the medications themselves. Which drugs cross the placenta, when to pause treatment, and how to plan a delivery on biologic therapy are questions that need a coordinated answer from both your gastroenterologist and obstetrician.

For a detailed look at treatment planning and what to expect each trimester, see our article on Crohn's disease and pregnancy.